Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct

Updated on May 30, 2020 12:41 PM IST
Copy Link

Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible. He said, “The study was published in Lancet on hydroxychloroquine and chloroquine and its effect on COVID-19 is an observational study.” He added that the statistical analysis in the Lancet paper is faulty. Watch the full video for more.

Story Saved
Saved Articles
My Reads
Sign out
New Delhi 0C
Tuesday, November 30, 2021